Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund Highlights: Ken Griffin, Stanley Druckenmiller, Herbalife Ltd. (HLF)

Page 1 of 2

Editor’s Note: YRC Worldwide, Inc. (NASDAQ:YRCW), Herbalife Ltd. (NYSE:HLF), Goldman Sachs Group, Inc. (NYSE:GS)

Citadel’s Ken Griffin says derivatives trading safer and more efficient (Opalesque)
Derivatives trading has improved dramatically, becoming safer and more efficient through post-crisis reforms that have shifted power from bank “dealers” to investors, according to Ken Griffin, founder of one of the world’s biggest hedge funds. “The dealers spoke about fire and brimstone, that markets would cease to work, products would become illiquid, costs would go up dramatically, clients would endure adverse consequences,” Mr Griffin, head of Citadel, the Chicago-based hedge fund, told the Financial Times.


Druckenmiller Says Fed Exit Would Be ‘Big Deal’ for Markets (San Francisco Chronicle)
Stanley Druckenmiller, who boasts one of the hedge-fund industry’s best long-term track records of the past three decades, said it would be a “big deal” for financial markets if the Federal Reserve were to completely end its asset purchases as outlined over the next 12 months. “How in the world does anyone think when the actual exit happens that prices are not going to respond?” Druckenmiller said today on Bloomberg Television’s “Market Makers” with Erik Schatzker and Stephanie Ruhle, given the selloff in bonds and emerging markets in the past few months on the mere hint that the Fed might taper its purchases.

Ackman Attempts to Frighten Herbalife (HLF) Auditor (
Shares of Herbalife Ltd. (NYSE:HLF) decline Wednesday, dropping 2% intraday as Bill Ackman stepped up his attacks on the so-called pyramid scheme. A 52-page letter from Ackman to Herbalife’s new auditor, PricewaterhouseCooper, was obtained by the New York Post. The letter appears to be an attempt by the hedge fund manager to raise alarm bells ahead of potential audit approval. Herbalife Ltd. (NYSE:HLF) hired PricewaterhouseCooper after its previous accountant, KPMG, resign due to an unrelated insider trading scandal.

Tiger Global Readies $1 Billion Long-Only Fund (FINalternatives)
Tiger Global Management, one of the most successful hedge funds in recent years, is doing away with the hedge for its latest fund. The New York-based firm is planning a long-only vehicle to be helmed by founder Chase Coleman and two other portfolio managers, Feroz Dewan and Scott Shleifer. The fund is expected to debut on Oct. 1 with between $1 billion and $1.5 billion in initial assets. Tiger Global has more than $11 billion in assets, even after returning $2 billion to investors late last year.

Mastic Hedge Fund Appoints James O’Brien as Chief Executive (Bloomberg)
Mastic Investment Advisory AG, the Zug, Switzerland-based commodities hedge fund, appointed James O’Brien as chief executive officer and chief risk officer. O’Brien is a former colleague of Mastic Chief Investment Officer Kieran McKenna from Goldman Sachs Group, Inc. (NYSE:GS), according to a letter to investors obtained by Bloomberg News. O’Brien has since held senior trading roles at Cargill Inc., Lehman Brothers Holdings Inc. and Fortis Bank SA, the letter showed. The appointment was confirmed today by a Mastic official who asked not to be identified in line with company policy. McKenna worked as a trader at Goldman from 1997 to 2004 before spells at Deutsche Bank AG, Citadel LLC, JPMorgan Chase & Co. and Credit Suisse Group AG.

Stanley Druckenmiller: Fed Choice Totally Matters to Market (Bloomberg)

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!